Article

A Customized Regulatory Approach to CMCs

Chemistry, manufacturing and controls strategies differ widely for various pharmaceutical products.

Khanh Ngo Courtney, Ph.D., Element’s senior director of biologics, joins a round table of other industry experts to discuss how these varied approaches are factored into regulatory strategy.

Read the full article in BioPharm International.

View more articles about

Find related articles to you through the Nucleus

A Customized Regulatory Approach to CMCs

Read the full article in BioPharm International

Our team of over 6,000 Engaged Experts in North America, Europe, The Middle East, Australia, Asia and Africa are ready to help you.